The DM-DEGs and associated pathways identified in this study—such as the PPAR and insulin signaling pathways—not only enhance our understanding of how diabetes influences UCEC pathogenesis but also lay a solid foundation for developing individualized therapeutic strategies for patients with both diabetes and endometrial cancer. Here, PPARA is linked to diabetes mellitus.